Confirmed cases in the Democratic Republic of the Congo's Bundibugyo Ebola outbreak passed 10,000 on 27 October 2026 - 10,060 cases and 4,887 deaths in government data.
It is already the second-largest Ebola outbreak on record, after the 2013-16 West Africa epidemic, and the largest ever caused by the Bundibugyo species.
Ituri province is the epicentre; eight DRC provinces are affected, and Kenya (9 cases) and Nigeria (1 case) have imported cases. Uganda's 20-case outbreak was declared over.
About 80% of new cases were arising outside monitored chains of transmission, against Africa CDC's control benchmark of at least 95% from known contacts.
No licensed vaccine or drug exists for Bundibugyo; the TUMAINI Phase 2/3 trial, starting with Ervebo, began in Bunia on 23 October.
Legally binding WHO instrument under which the Director-General declares a PHEIC; declared for this outbreak on 17 May 2026
Declared the PHEIC; publishes Disease Outbreak News
African Union public health agency; declared a continental emergency on 18 May
Coordinates the TUMAINI Phase 2/3 vaccine trial in Bunia
Ituri lies in north-eastern DRC on the border with Uganda and South Sudan; Bunia is its capital and Mongbwalu, where early infections are traced, is a gold-mining town in the province. North Kivu, the second-worst-hit province, lies to its south.
Ebola first identified in Yambuku (DRC) and Nzara (South Sudan)
Bundibugyo virus first identified in Uganda's Bundibugyo District
Bundibugyo outbreak in Isiro, DRC
Current outbreak reported in Ituri; DRC and Uganda declare outbreaks
WHO PHEIC; Africa CDC continental emergency
Ervebo vaccination of frontline workers begins in Kisangani; WHO declares Uganda's outbreak over
Nigeria confirms its first case
TUMAINI Phase 2/3 vaccine trial starts in Bunia
DRC confirmed cases pass 10,000
GS Paper III > Science and Technology - health, diseases; GS Paper II > International institutions (WHO, IHR)
General Science > Diseases and pathogens
Public Health Emergency of International Concern - WHO's highest alert under the IHR, 2005
Family of thread-shaped RNA viruses that includes Ebola and Marburg
rVSV-based vaccine licensed against Zaire ebolavirus; being tested for cross-protection against Bundibugyo